Mohammad Al-Mahdi Al-Karagholi is a medical doctor and postdoctoral researcher with a research interest in therapeutic novelties in migraine. In the past six years, he has been studying the role of ion channels in migraine pathophysiology in migraine with and without aura patients. He has also been involved in clinical trials investigating migraine prevention with monoclonal antibodies.